ApicHope Pharmaceutical Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Hanxiong Li
Chief executive officer
CN¥653.6k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 16.1% |
| Management average tenure | no data |
| Board average tenure | less than a year |
Recent management updates
Recent updates
Revenues Not Telling The Story For ApicHope Pharmaceutical Co., Ltd (SZSE:300723) After Shares Rise 30%
Dec 06
Revenues Not Telling The Story For ApicHope Pharmaceutical Co., Ltd (SZSE:300723) After Shares Rise 38%
Oct 09Does ApicHope Pharmaceutical (SZSE:300723) Have A Healthy Balance Sheet?
Jun 27ApicHope Pharmaceutical (SZSE:300723) Is Paying Out A Larger Dividend Than Last Year
May 27ApicHope Pharmaceutical's (SZSE:300723) Shareholders Have More To Worry About Than Only Soft Earnings
May 03Bearish: Analysts Just Cut Their ApicHope Pharmaceutical Co., Ltd (SZSE:300723) Revenue and EPS estimates
May 02ApicHope Pharmaceutical (SZSE:300723) Has A Pretty Healthy Balance Sheet
Mar 15Market Participants Recognise ApicHope Pharmaceutical Co., Ltd's (SZSE:300723) Earnings
Feb 27CEO
Hanxiong Li (50 yo)
no data
Tenure
CN¥653,600
Compensation
Mr. Hanxiong Li serves as Chairman of the Board of Directors and General Manager at ApicHope Pharmaceutical Co., Ltd (formerly Yipinhong Pharmaceutical Co., Ltd). He is Director of Arthrosi Therapeutics, I...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board of Directors & GM | no data | CN¥653.60k | 16.06% CN¥ 1.4b | |
| Deputy GM & Non-Independent Director | no data | CN¥1.32m | no data | |
| Independent Director | less than a year | no data | no data | |
| Non-Employee Supervisor | less than a year | CN¥1.01m | no data | |
| Non-Independent Director | no data | CN¥453.60k | 3.04% CN¥ 255.9m | |
| Chairman of the Supervisory Board | no data | no data | no data | |
| Supervisor | 3yrs | no data | no data | |
| Non-Employee Supervisor | no data | no data | no data | |
| Independent Director | 3yrs | CN¥120.00k | no data | |
| Independent Director | 3yrs | CN¥120.00k | 0.0044% CN¥ 374.9k | |
| Non-Employee Supervisor | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data |
0.4yrs
Average Tenure
50yo
Average Age
Experienced Board: 300723's board of directors are not considered experienced ( 0.4 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 17:51 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ApicHope Pharmaceutical Co., Ltd is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kehan Meng | Haitong International Research Limited |
| Wen Dai | Huatai Research |
| Jiaxi Xu | Industrial Securities Co. Ltd. |